lvrachЛечащий ВрачLechaschi Vrach1560-51752687-1181lvrach-474Research ArticleСтатьиАлгоритм обследования пациентов с новообразованиями кожиImmunity indices in patients with atopic dermatitis with different polymorphisms in Glutathioni-S-Transferase genesКубановА. А.KubanovA. A.derma2006@yandex.ruСысоеваТ. А.SysoevaT. A.noemail@neicon.ruГаллямоваЮ. А.GallyamovaYu. A.noemail@neicon.ruБишароваА. С.BisharovaA. S.noemail@neicon.ruМерцаловаИ. Б.MertsalovaI. B.noemail@neicon.ru201823062021038383Copyright © Кубанов А.А., Сысоева Т.А., Галлямова Ю.А., Бишарова А.С., Мерцалова И.Б., 20212021Кубанов А.А., Сысоева Т.А., Галлямова Ю.А., Бишарова А.С., Мерцалова И.Б.Kubanov A.A., Sysoeva T.A., Gallyamova Y.A., Bisharova A.S., Mertsalova I.B.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.lvrach.ru/jour/article/view/474

В статье приведены современные данные о факторах риска злокачественных новообразований кожи. Представлен алгоритм опроса и осмотра, схема дерматоскопического заключения пациента с меланоцитарными новообразованиями кожи.

Results of the genetic typing and immunologic analysis in patients with atopic dermatitis are presented. Various genetic polymorphisms in genes of GST (M1, T1 and P1) were described in patients with atopic dermatitis. The whole set of the results obtained indicates the necessity to pay attention to the detoxication abnormalities in patient with atopic dermatitis while working out personalized treatment and preventive measures. 

МеланомаАктуальная темаБазальноклеточный ракФакторы рискаДерматоскопияАвтоматизированная картографияДиагностикаatopic dermatitisgeneticspolymorphisms in genes of GSTgastro-intestinal disorders in patients with atopic dermatitisReferencesДемидов Л. В, Утяшев И. А., Харкевич Г. Ю. Подходы к диагностике и терапии меланомы кожи: эра персонализированной медицины // Consilium Medicum. 2013; 2–3: 42–47.Демидов Л. В, Утяшев И. А., Харкевич Г. Ю. Подходы к диагностике и терапии меланомы кожи: эра персонализированной медицины // Consilium Medicum. 2013; 2–3: 42–47.Состояние онкологической помощи населению России в 2016 году / Под ред. Карпина А. Д., Старинского В. В., Петровой Г. В.Состояние онкологической помощи населению России в 2016 году / Под ред. Карпина А. Д., Старинского В. В., Петровой Г. В.Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. Wellington: Cancer Council Australia and Australia Cancer Network, Sydney and New Zealand Guidelines Group, 2008.Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. Wellington: Cancer Council Australia and Australia Cancer Network, Sydney and New Zealand Guidelines Group, 2008.Алиев М. Д., Бохян Б. Ю., Демидов Л. В. и др. Клинические рекомендации по диагностике и лечению больных меланомой кожи. М., 2014.Алиев М. Д., Бохян Б. Ю., Демидов Л. В. и др. Клинические рекомендации по диагностике и лечению больных меланомой кожи. М., 2014.Rutkowski P., Wysocki P. J., Nowecki Z. I. et al. Cutaneous melanoma: diagnostic and therapeutic guidelines in 2013 // Przegl Dermatol. 2013; 100: 1–15.Rutkowski P., Wysocki P. J., Nowecki Z. I. et al. Cutaneous melanoma: diagnostic and therapeutic guidelines in 2013 // Przegl Dermatol. 2013; 100: 1–15.Guidelines Working Group. National Guidelines for Diagnosis, Treatment and Follow-up of Malignant Melanomas. Oslo: Norwegian Directorateof Health, 2011.Guidelines Working Group. National Guidelines for Diagnosis, Treatment and Follow-up of Malignant Melanomas. Oslo: Norwegian Directorateof Health, 2011.Чиссов В. И., Старинский В. В., Петрова Г. В. Злокачественные новообразования в России в 2008 г. (заболеваемость и смертность). М.: ФГУ «МНИОИ им. П. А. Герцена Росмедтехнологий», 2010.Чиссов В. И., Старинский В. В., Петрова Г. В. Злокачественные новообразования в России в 2008 г. (заболеваемость и смертность). М.: ФГУ «МНИОИ им. П. А. Герцена Росмедтехнологий», 2010.Zhang H., Bermejo J. L., Sundquist J. et al. Modification of second cancer risk after malignant melanoma by parental history of cancer // Br J Cancer. 2008; 99: 536–388.Zhang H., Bermejo J. L., Sundquist J. et al. Modification of second cancer risk after malignant melanoma by parental history of cancer // Br J Cancer. 2008; 99: 536–388.Crocetti E., Guzzinati S., Paci E. et al. The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries) // Melanoma Res. 2008; 18: 230–234.Crocetti E., Guzzinati S., Paci E. et al. The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries) // Melanoma Res. 2008; 18: 230–234.Gandini S., Sera F., Cattaruzza M. S. et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi // European Journalof Cancer. 2005; 41: 28–44.Gandini S., Sera F., Cattaruzza M. S. et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi // European Journalof Cancer. 2005; 41: 28–44.Olsen C. M., Carroll H. J., Whiteman D. C. Estimating the attributable fraction for cancer: A meta-analysis of nevi and melanoma // Cancer Prev Res (Phila). 2010; 3: 233–245.Olsen C. M., Carroll H. J., Whiteman D. C. Estimating the attributable fraction for cancer: A meta-analysis of nevi and melanoma // Cancer Prev Res (Phila). 2010; 3: 233–245.Olsen C. M., Carroll H. J., Whiteman D. C. Estimating the attributable fraction for melanoma: a meta-analysis of pigmentary characteristics and freckling // Int J Cancer. 2010; 127: 2430–2445.Olsen C. M., Carroll H. J., Whiteman D. C. Estimating the attributable fraction for melanoma: a meta-analysis of pigmentary characteristics and freckling // Int J Cancer. 2010; 127: 2430–2445.Olsen C. M., Zens M. S., Green A. C. et al. Biologic markers of sun exposure and melanoma risk in women: Pooled case–control analysis // Int J Cancer. 2011; 129: 713–723.Olsen C. M., Zens M. S., Green A. C. et al. Biologic markers of sun exposure and melanoma risk in women: Pooled case–control analysis // Int J Cancer. 2011; 129: 713–723.Dennis L. K., Vanbeek M. J., Beane Freeman L. E. et al. Sunburns and risk of cutaneous melanoma: does age matter? A comprehensivemeta-analysis // Ann Epidemiol. 2008; 18: 614–627.Dennis L. K., Vanbeek M. J., Beane Freeman L. E. et al. Sunburns and risk of cutaneous melanoma: does age matter? A comprehensivemeta-analysis // Ann Epidemiol. 2008; 18: 614–627.Coelho S. G., Hearing V. J. UVA tanning is involved in the increased incidence of skin cancers in fair-skinned young women // Pigment Cell Melanoma Res. 2010; 23: 57–63.Coelho S. G., Hearing V. J. UVA tanning is involved in the increased incidence of skin cancers in fair-skinned young women // Pigment Cell Melanoma Res. 2010; 23: 57–63.Boniol M., Autier P., Boyle P. et al. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis // BMJ. 2012; 345: e4757. DOI: 10. 1136/bmj.e4757.Boniol M., Autier P., Boyle P. et al. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis // BMJ. 2012; 345: e4757. DOI: 10. 1136/bmj.e4757.Colantonio S., Bracken M. B., Beecker J. The association of indoor tanning and melanoma in adults: Systematic review and meta-analysis // J Am Acad Dermatol. 2014; 70 (5): 847–857.Colantonio S., Bracken M. B., Beecker J. The association of indoor tanning and melanoma in adults: Systematic review and meta-analysis // J Am Acad Dermatol. 2014; 70 (5): 847–857.Rees J. R., Zens M. S., Gui J. et al. Non melanoma skin cancer and subsequent cancer risk // PLoS One. 2014, Jun; 9 (6).Rees J. R., Zens M. S., Gui J. et al. Non melanoma skin cancer and subsequent cancer risk // PLoS One. 2014, Jun; 9 (6).Bonadies D. C., Bale A. E. Hereditary melanoma // Current Problemsin Cancer. 2011; 35: 162–172.Bonadies D. C., Bale A. E. Hereditary melanoma // Current Problemsin Cancer. 2011; 35: 162–172.Bradford P. T., Freedman D. M., Goldstein A. M. et al. Increased risk of second primary cancers after a diagnosis of melanoma // Arch Dermatol. 2010; 146: 265–272.Bradford P. T., Freedman D. M., Goldstein A. M. et al. Increased risk of second primary cancers after a diagnosis of melanoma // Arch Dermatol. 2010; 146: 265–272.Yang G. B., Barnholtz-Sloan J. S., Chen Y. et al. Risk and Survival of Cutaneous Melanoma Diagnosed Subsequent to a Previous Cancer // Archivesof Dermatology. 2011; 147: 1395–1402.Yang G. B., Barnholtz-Sloan J. S., Chen Y. et al. Risk and Survival of Cutaneous Melanoma Diagnosed Subsequent to a Previous Cancer // Archivesof Dermatology. 2011; 147: 1395–1402.Goggins W., Gao W., Tsao H. Association between female breast cancer and cutaneous melanoma // Int J Cancer. 2004; 111: 792–794.Goggins W., Gao W., Tsao H. Association between female breast cancer and cutaneous melanoma // Int J Cancer. 2004; 111: 792–794.Li W. Q., Qureshi A. A., Ma J. et al. Personal History of Prostate Cancer and Increased Risk of Incident Melanoma in the United States // J Clin Oncol. 2013, November 4, 51.Li W. Q., Qureshi A. A., Ma J. et al. Personal History of Prostate Cancer and Increased Risk of Incident Melanoma in the United States // J Clin Oncol. 2013, November 4, 51.Olsen C. M., Lane S. W., Green A. C. Increased risk of melanoma in patients with chronic lymphocytic leukaemia: systematic review and meta-analysis of cohort studies // Melanoma Res. 2016, Apr; 26 (2): 188–194.Olsen C. M., Lane S. W., Green A. C. Increased risk of melanoma in patients with chronic lymphocytic leukaemia: systematic review and meta-analysis of cohort studies // Melanoma Res. 2016, Apr; 26 (2): 188–194.Green A. C., Olsen C. M. Increased risk of melanoma in organ transplant recipients: systematic review and meta-analysis of cohort studies // Acta Derm Venereol. 2015, Nov; 95 (8): 923–927.Green A. C., Olsen C. M. Increased risk of melanoma in organ transplant recipients: systematic review and meta-analysis of cohort studies // Acta Derm Venereol. 2015, Nov; 95 (8): 923–927.Olsen C. M., Knight L. L., Green A. C. Risk of melanoma in people with HIV/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies // PLoSOne. 2014; 9 (4): e95096.Olsen C. M., Knight L. L., Green A. C. Risk of melanoma in people with HIV/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies // PLoSOne. 2014; 9 (4): e95096.Van der Leest R. J., Flohil S. C., Arends L. R. et al. Risk of subsequent cutaneous malignancy in patients with prior melanoma: a systematic review and meta-analysis // J Eur Acad Dermatol Venereol. 2015, Jun; 29 (6): 1053–1062.Van der Leest R. J., Flohil S. C., Arends L. R. et al. Risk of subsequent cutaneous malignancy in patients with prior melanoma: a systematic review and meta-analysis // J Eur Acad Dermatol Venereol. 2015, Jun; 29 (6): 1053–1062.Singh S., Nagpal S. J., Murad M. H. et al. Inflammatory Bowel Disease Is Associated With an Increased Risk of Melanoma: A Systematic Review and Meta-Analysis // Clin Gastroenterol Hepatol. 2013. DOI: 10.1016/j.cgh.2013.04.033.Singh S., Nagpal S. J., Murad M. H. et al. Inflammatory Bowel Disease Is Associated With an Increased Risk of Melanoma: A Systematic Review and Meta-Analysis // Clin Gastroenterol Hepatol. 2013. DOI: 10.1016/j.cgh.2013.04.033.Simon T. A., Thompson A., Gandhi K. K. et al. Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis // Arthritis Res Ther. 2015, Aug 15; 17: 212.Simon T. A., Thompson A., Gandhi K. K. et al. Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis // Arthritis Res Ther. 2015, Aug 15; 17: 212.Fallah M., Pukkala E., Sundquist K. et al. Familial melanoma by histology and age: Joint data from five Nordic countries // Eur J Cancer. 2014, Apr; 50 (6): 1176–1183.Fallah M., Pukkala E., Sundquist K. et al. Familial melanoma by histology and age: Joint data from five Nordic countries // Eur J Cancer. 2014, Apr; 50 (6): 1176–1183.Qureshi A. A., Zhang M., Han J. Heterogeneity in host risk factors for incident melanoma and non-melanoma skin cancer in a cohort of US women // J Epidemiol. 2011; 21: 197–203.Qureshi A. A., Zhang M., Han J. Heterogeneity in host risk factors for incident melanoma and non-melanoma skin cancer in a cohort of US women // J Epidemiol. 2011; 21: 197–203.Sanlorenzo M., Wehner M. R., Linos E. et al. The Risk of Melanoma in Airline Pilots and Cabin Crew: A Meta-analysis // JAMA Dermatol. 2015; 151 (1): 51–58.Sanlorenzo M., Wehner M. R., Linos E. et al. The Risk of Melanoma in Airline Pilots and Cabin Crew: A Meta-analysis // JAMA Dermatol. 2015; 151 (1): 51–58.Young C., Rushton L. Occupational cancer in Britain: Skin cancer // Br J Cancer. 2012; 107, Suppl 1: S71–5.Young C., Rushton L. Occupational cancer in Britain: Skin cancer // Br J Cancer. 2012; 107, Suppl 1: S71–5.Schmitt J., Seidler A., Diepgen T. L., Bauer A. Occupational ultraviolet light exposure increases the risk for the development of cutaneous squamous cell carcinoma: a systematic review and meta-analysis // Br J Dermatol. 2011; 164: 291–307.Schmitt J., Seidler A., Diepgen T. L., Bauer A. Occupational ultraviolet light exposure increases the risk for the development of cutaneous squamous cell carcinoma: a systematic review and meta-analysis // Br J Dermatol. 2011; 164: 291–307.Crocetti E., Guzzinati S., Paci E. et al. The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries) // Melanoma Res. 2008; 18: 230–234.Crocetti E., Guzzinati S., Paci E. et al. The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries) // Melanoma Res. 2008; 18: 230–234.Gandini S., Sera F., Cattaruzza M. S. et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi // European Journal of Cancer. 2005; 41: 28–44.Gandini S., Sera F., Cattaruzza M. S. et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi // European Journal of Cancer. 2005; 41: 28–44.Olsen C. M., Carroll H. J., Whiteman D. C. Estimating the attributable fraction for cancer: A meta-analysis of nevi and melanoma // Cancer Prev Res (Phila). 2010; 3: 233–245.Olsen C. M., Carroll H. J., Whiteman D. C. Estimating the attributable fraction for cancer: A meta-analysis of nevi and melanoma // Cancer Prev Res (Phila). 2010; 3: 233–245.Bauer J., Garbe C. Acquired Melanocytic Nevi as Risk Factor for Melanoma Development. A Comprehensive Review of Epidemiological Data // Pigment Cell Res. 2003; 16: 297–306.Bauer J., Garbe C. Acquired Melanocytic Nevi as Risk Factor for Melanoma Development. A Comprehensive Review of Epidemiological Data // Pigment Cell Res. 2003; 16: 297–306.Celebi J. T., Ward K. M., Wanner M., Polsky D., Kopf A. W. Evaluation of germline CDKN2 A, ARF, CDK4, PTEN, and BRAF alterations in atypical mole syndrome // Clin Exp Dermatol. 2005; 30: 68–70.Celebi J. T., Ward K. M., Wanner M., Polsky D., Kopf A. W. Evaluation of germline CDKN2 A, ARF, CDK4, PTEN, and BRAF alterations in atypical mole syndrome // Clin Exp Dermatol. 2005; 30: 68–70.Jeremy Nikfarjam, Earle Chambers. Congenital Melanocytic Nevi and the Risk of Malignant Melanoma: Establishing a Guideline for Primary-Care Physicians // The Einstein Journal of Biology and Medicine. 2012; 11–18.Jeremy Nikfarjam, Earle Chambers. Congenital Melanocytic Nevi and the Risk of Malignant Melanoma: Establishing a Guideline for Primary-Care Physicians // The Einstein Journal of Biology and Medicine. 2012; 11–18.Quaba A. A., Wallace A. F. The incidence of malignant melanoma (0 to 15 years of age) arising in «large» congenital nevocellular nevi // Plast Reconstr Surg. 1986, 78 (2): 174–181.Quaba A. A., Wallace A. F. The incidence of malignant melanoma (0 to 15 years of age) arising in «large» congenital nevocellular nevi // Plast Reconstr Surg. 1986, 78 (2): 174–181.Ruiz-Maldonado R., Tamayo L., Laterza A. M., Dur?n C. Giant pigmented nevi: Clinical, histopathologic, and therapeutic considerations // J Pediatr. 1992, 120 (6): 906–911.Ruiz-Maldonado R., Tamayo L., Laterza A. M., Dur?n C. Giant pigmented nevi: Clinical, histopathologic, and therapeutic considerations // J Pediatr. 1992, 120 (6): 906–911.Abbasi N. R., Shaw H. M., Rigel D. S. et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria // JAMA. 2004; 292: 2771–2776.Abbasi N. R., Shaw H. M., Rigel D. S. et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria // JAMA. 2004; 292: 2771–2776.Grob J. J., Bonerandi J. J. The ‘ugly duckling’ sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening // Arch Dermatol. 1998; 134 (1): 103–104.Grob J. J., Bonerandi J. J. The ‘ugly duckling’ sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening // Arch Dermatol. 1998; 134 (1): 103–104.Mascaro J. M. Jr., Mascaro J. M. The dermatologist’s position concerning nevi: a vision ranging from ‘the ugly duckling’ to ‘little red riding hood’ // Arch. Dermatol. 1998, 134, 1484–1485.Mascaro J. M. Jr., Mascaro J. M. The dermatologist’s position concerning nevi: a vision ranging from ‘the ugly duckling’ to ‘little red riding hood’ // Arch. Dermatol. 1998, 134, 1484–1485.Kittler H., Pehamberger H., Wolff K., Binder M. Diagnostic accuracy of dermoscopy // Lancet Oncol. 2002; 3: 159–165.Kittler H., Pehamberger H., Wolff K., Binder M. Diagnostic accuracy of dermoscopy // Lancet Oncol. 2002; 3: 159–165.Blum A., Hofmann-Wellenhof R., Luedtke H., Ellwanger U., Steins A., Roehm S., Garbe C., Soyer H. P. Blackwell Publishing, Ltd. Value of the clinical history for different users of dermoscopy compared with results of digital image analysis // JEADV. 2004, 18, 665–669.Blum A., Hofmann-Wellenhof R., Luedtke H., Ellwanger U., Steins A., Roehm S., Garbe C., Soyer H. P. Blackwell Publishing, Ltd. Value of the clinical history for different users of dermoscopy compared with results of digital image analysis // JEADV. 2004, 18, 665–669.Bengu N. Akay. Correspondence: Dermatoscopy of a melanoma less than one millimeter in diameter // International Journal of Dermatology. 2017.Bengu N. Akay. Correspondence: Dermatoscopy of a melanoma less than one millimeter in diameter // International Journal of Dermatology. 2017.

The authors declare that there are no conflicts of interest present.